BioSpace News Archive

Business

Alexandria LaunchLabs Grants First Seed Capital to Holobiome in Cambridge

Alexandria Real Estate Equities, which focuses on development of life science and technology campuses, launched its inaugural member class of seed- and early-stage life science companies at the Alexandria LaunchLabs – Cambridge.

April 10, 2019
·
3 min read
·
Mark Terry
Business

Ambry Genetics Makes Advances in RNA Genetic Testing

Seattle-based Ambry Genetics recently presented data at the American College of Medical Genetics and Genomics annual meeting describing the results of supplemental RNA genetic testing data.

April 10, 2019
·
4 min read
·
Mark Terry
New generation of sensors for concentration measurement and monitoring of cell growth

EXNER’s new generation of the EXcell sensor series not only provides the end user with higher flexibility during application, but at the same time allows safer processing.

April 10, 2019
·
2 min read
Biotech Beach

DCN Diagnostics to Distribute nanoComposix Gold NanoShell Particles

New deal expands labelling reagent options available through DCNovations

April 10, 2019
·
2 min read
Business

First Light Diagnostics Welcomes New Vice President of Quality Assurance and Regulatory Affairs

First Light Diagnostics, a developer of breakthrough automated products for the rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, announced the hiring of Andrew Connerty as its vice president of quality assurance and regulatory affairs.

April 10, 2019
·
2 min read
Business

Pfizer Inks Real-World Oncology Data Collaboration With Concerto HealthAI

Only a few weeks after Concerto HealthAI inked a deal with Bristol-Myers Squibb, it has signed a similar deal with Pfizer.

April 10, 2019
·
3 min read
·
Mark Terry
Drug Development

Metabo-Oncology: The Latest Frontier in Cancer Research

Metabo-oncology is the study of the effects that metabolic dysfunction and obesity have on cancer and cancer treatments. This includes both how they affect those who already have cancer as well as how they may increase the odds of one getting cancer later on in life.

April 10, 2019
·
3 min read
·
Sasha Mortimer
Business

Angion Biomedica Nears End of Clinical Trials for Organ-Repairing Molecule

Repairing a damaged organ in order to allow an individual to have a healthier life, as well as a greater quality of life, could soon be a reality as New York-based Angion Biomedica Corp. moves toward completing clinical trials of its lead asset.

April 10, 2019
·
3 min read
·
Alex Keown
Business

Coquí Pharma on Track to Build Medical Isotope Production Facility in Tennessee

Coquí Radio Pharmaceuticals Corp. is closer to realizing its goal of building a dedicated Medical Isotope Production Facility in Oak Ridge, Tennessee, after the U.S. Department of Energy (DOE) transferred land for the facility and provided research support through the national laboratories.

April 10, 2019
·
2 min read
Sanofi Cuts the Costs of Some Insulin Products to $99 per Month

The French drugmaker expanded its one-year-old Valyou Savings Program to lower the cost of up to 10 boxes of pens and 10 boxes of vials to $99 per month.

April 10, 2019
·
3 min read
·
Alex Keown